ISX	B:C0022266
-	I:C0022266
9	I:C0022266
can	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
commitment	O
in	O
the	O
rat	O
dentate	O
gyrus	I:C0152314
.	O

ISX	O
-	I:C0022266
9	I:C0022266
can	O
potentiate	O
cell	B:C0596290
proliferation	I:C0596290
and	O
neuronal	O
commitment	O
in	O
the	O
rat	O
dentate	O
gyrus	I:C0152314
.	O

ISX	O
-	I:C0022266
9	I:C0022266
can	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
neuronal	B:C0027882
commitment	O
in	O
the	O
rat	O
dentate	O
gyrus	I:C0152314
.	O

ISX	O
-	I:C0022266
9	I:C0022266
can	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
commitment	B:C1160036
in	O
the	O
rat	O
dentate	O
gyrus	I:C0152314
.	O

ISX	O
-	I:C0022266
9	I:C0022266
can	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
commitment	O
in	O
the	O
rat	B:C0086893
dentate	O
gyrus	I:C0152314
.	O

ISX	O
-	I:C0022266
9	I:C0022266
can	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
commitment	O
in	O
the	O
rat	O
dentate	B:C0152314
gyrus	I:C0152314
.	O

Adult	O
hippocampal	B:C0019564
neurogenesis	O
can	O
be	O
modulated	O
by	O
various	O
physiological	O
and	O
pathological	O
conditions	I:C0752135
,	O
including	O
stress	O
,	O
affective	O
disorders	I:C0525045
,	O
and	O
several	O
neurological	O
conditions	O
.	O

Adult	O
hippocampal	O
neurogenesis	B:C0814002
can	O
be	O
modulated	O
by	O
various	O
physiological	O
and	O
pathological	O
conditions	I:C0752135
,	O
including	O
stress	O
,	O
affective	O
disorders	I:C0525045
,	O
and	O
several	O
neurological	O
conditions	O
.	O

Adult	O
hippocampal	O
neurogenesis	O
can	O
be	O
modulated	B:C0443264
by	O
various	O
physiological	O
and	O
pathological	O
conditions	I:C0752135
,	O
including	O
stress	O
,	O
affective	O
disorders	I:C0525045
,	O
and	O
several	O
neurological	O
conditions	O
.	O

Adult	O
hippocampal	O
neurogenesis	O
can	O
be	O
modulated	O
by	O
various	O
physiological	O
and	O
pathological	B:C0752135
conditions	I:C0752135
,	O
including	O
stress	O
,	O
affective	O
disorders	I:C0525045
,	O
and	O
several	O
neurological	O
conditions	O
.	O

Adult	O
hippocampal	O
neurogenesis	O
can	O
be	O
modulated	O
by	O
various	O
physiological	O
and	O
pathological	O
conditions	I:C0752135
,	O
including	O
stress	B:C0038435
,	O
affective	O
disorders	I:C0525045
,	O
and	O
several	O
neurological	O
conditions	O
.	O

Adult	O
hippocampal	O
neurogenesis	O
can	O
be	O
modulated	O
by	O
various	O
physiological	O
and	O
pathological	O
conditions	I:C0752135
,	O
including	O
stress	O
,	O
affective	B:C0525045
disorders	I:C0525045
,	O
and	O
several	O
neurological	O
conditions	O
.	O

Given	O
the	O
proposed	O
role	O
of	O
this	O
form	O
of	O
structural	O
plasticity	O
in	O
the	O
functioning	B:C0031843
of	O
the	O
hippocampus	O
(	O
namely	O
learning	O
and	O
memory	O
and	O
affective	O
behaviors	O
)	O
,	O
it	O
is	O
believed	O
that	O
alterations	O
in	O
hippocampal	O
neurogenesis	O
might	O
underlie	O
some	O
of	O
the	O
behavioral	O
deficits	O
associated	O
with	O
these	O
psychiatric	O
and	O
neurological	O
conditions	O
.	O

Given	O
the	O
proposed	O
role	O
of	O
this	O
form	O
of	O
structural	O
plasticity	O
in	O
the	O
functioning	O
of	O
the	O
hippocampus	B:C0019564
(	O
namely	O
learning	O
and	O
memory	O
and	O
affective	O
behaviors	O
)	O
,	O
it	O
is	O
believed	O
that	O
alterations	O
in	O
hippocampal	O
neurogenesis	O
might	O
underlie	O
some	O
of	O
the	O
behavioral	O
deficits	O
associated	O
with	O
these	O
psychiatric	O
and	O
neurological	O
conditions	O
.	O

Given	O
the	O
proposed	O
role	O
of	O
this	O
form	O
of	O
structural	O
plasticity	O
in	O
the	O
functioning	O
of	O
the	O
hippocampus	O
(	O
namely	O
learning	B:C0023185
and	O
memory	O
and	O
affective	O
behaviors	O
)	O
,	O
it	O
is	O
believed	O
that	O
alterations	O
in	O
hippocampal	O
neurogenesis	O
might	O
underlie	O
some	O
of	O
the	O
behavioral	O
deficits	O
associated	O
with	O
these	O
psychiatric	O
and	O
neurological	O
conditions	O
.	O

Given	O
the	O
proposed	O
role	O
of	O
this	O
form	O
of	O
structural	O
plasticity	O
in	O
the	O
functioning	O
of	O
the	O
hippocampus	O
(	O
namely	O
learning	O
and	O
memory	B:C0025260
and	O
affective	O
behaviors	O
)	O
,	O
it	O
is	O
believed	O
that	O
alterations	O
in	O
hippocampal	O
neurogenesis	O
might	O
underlie	O
some	O
of	O
the	O
behavioral	O
deficits	O
associated	O
with	O
these	O
psychiatric	O
and	O
neurological	O
conditions	O
.	O

Given	O
the	O
proposed	O
role	O
of	O
this	O
form	O
of	O
structural	O
plasticity	O
in	O
the	O
functioning	O
of	O
the	O
hippocampus	O
(	O
namely	O
learning	O
and	O
memory	O
and	O
affective	O
behaviors	O
)	O
,	O
it	O
is	O
believed	O
that	O
alterations	O
in	O
hippocampal	B:C0019564
neurogenesis	O
might	O
underlie	O
some	O
of	O
the	O
behavioral	O
deficits	O
associated	O
with	O
these	O
psychiatric	O
and	O
neurological	O
conditions	O
.	O

Given	O
the	O
proposed	O
role	O
of	O
this	O
form	O
of	O
structural	O
plasticity	O
in	O
the	O
functioning	O
of	O
the	O
hippocampus	O
(	O
namely	O
learning	O
and	O
memory	O
and	O
affective	O
behaviors	O
)	O
,	O
it	O
is	O
believed	O
that	O
alterations	O
in	O
hippocampal	O
neurogenesis	B:C0814002
might	O
underlie	O
some	O
of	O
the	O
behavioral	O
deficits	O
associated	O
with	O
these	O
psychiatric	O
and	O
neurological	O
conditions	O
.	O

Thus	O
,	O
the	O
search	O
for	O
compounds	B:C1254351
that	O
can	O
reverse	O
these	O
deficits	O
with	O
minimal	O
side	O
effects	I:C0879626
has	O
become	O
a	O
recognized	O
priority	O
.	O

Thus	O
,	O
the	O
search	O
for	O
compounds	O
that	O
can	O
reverse	O
these	O
deficits	O
with	O
minimal	O
side	B:C0879626
effects	I:C0879626
has	O
become	O
a	O
recognized	O
priority	O
.	O

In	O
the	O
present	O
study	B:C0008972
we	O
tested	O
the	O
pro-neurogenic	O
effects	O
of	O
isoxazole	O
9	I:C0022266
(	O
isoxazole	O
9	I:C0022266
)	O
,	O
a	O
small	O
synthetic	O
molecule	O
that	O
has	O
been	O
recently	O
identified	O
through	O
the	O
screening	O
of	I:C0373483
chemical	I:C0373483
libraries	I:C0373483
in	O
stem	O
cell	I:C0009385
-	I:C0009385
based	I:C0009385
assays	I:C0009385
.	O

In	O
the	O
present	O
study	O
we	O
tested	O
the	O
pro-neurogenic	O
effects	O
of	O
isoxazole	B:C0022266
9	I:C0022266
(	O
isoxazole	O
9	I:C0022266
)	O
,	O
a	O
small	O
synthetic	O
molecule	O
that	O
has	O
been	O
recently	O
identified	O
through	O
the	O
screening	O
of	I:C0373483
chemical	I:C0373483
libraries	I:C0373483
in	O
stem	O
cell	I:C0009385
-	I:C0009385
based	I:C0009385
assays	I:C0009385
.	O

In	O
the	O
present	O
study	O
we	O
tested	O
the	O
pro-neurogenic	O
effects	O
of	O
isoxazole	O
9	I:C0022266
(	O
isoxazole	B:C0022266
9	I:C0022266
)	O
,	O
a	O
small	O
synthetic	O
molecule	O
that	O
has	O
been	O
recently	O
identified	O
through	O
the	O
screening	O
of	I:C0373483
chemical	I:C0373483
libraries	I:C0373483
in	O
stem	O
cell	I:C0009385
-	I:C0009385
based	I:C0009385
assays	I:C0009385
.	O

In	O
the	O
present	O
study	O
we	O
tested	O
the	O
pro-neurogenic	O
effects	O
of	O
isoxazole	O
9	I:C0022266
(	O
isoxazole	O
9	I:C0022266
)	O
,	O
a	O
small	O
synthetic	O
molecule	O
that	O
has	O
been	O
recently	O
identified	O
through	O
the	O
screening	B:C0373483
of	I:C0373483
chemical	I:C0373483
libraries	I:C0373483
in	O
stem	O
cell	I:C0009385
-	I:C0009385
based	I:C0009385
assays	I:C0009385
.	O

In	O
the	O
present	O
study	O
we	O
tested	O
the	O
pro-neurogenic	O
effects	O
of	O
isoxazole	O
9	I:C0022266
(	O
isoxazole	O
9	I:C0022266
)	O
,	O
a	O
small	O
synthetic	O
molecule	O
that	O
has	O
been	O
recently	O
identified	O
through	O
the	O
screening	O
of	I:C0373483
chemical	I:C0373483
libraries	I:C0373483
in	O
stem	B:C0009385
cell	I:C0009385
-	I:C0009385
based	I:C0009385
assays	I:C0009385
.	O

We	O
found	O
that	O
administration	B:C1533734
of	O
isoxazole	O
9	I:C0022266
for	O
14days	O
was	O
able	O
to	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
increase	O
the	O
number	O
of	O
immature	O
neurons	O
in	O
the	O
hippocampal	O
DG	O
of	O
adult	O
rats	O
.	O

We	O
found	O
that	O
administration	O
of	O
isoxazole	B:C0022266
9	I:C0022266
for	O
14days	O
was	O
able	O
to	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
increase	O
the	O
number	O
of	O
immature	O
neurons	O
in	O
the	O
hippocampal	O
DG	O
of	O
adult	O
rats	O
.	O

We	O
found	O
that	O
administration	O
of	O
isoxazole	O
9	I:C0022266
for	O
14days	O
was	O
able	O
to	O
potentiate	O
cell	B:C0596290
proliferation	I:C0596290
and	O
increase	O
the	O
number	O
of	O
immature	O
neurons	O
in	O
the	O
hippocampal	O
DG	O
of	O
adult	O
rats	O
.	O

We	O
found	O
that	O
administration	O
of	O
isoxazole	O
9	I:C0022266
for	O
14days	O
was	O
able	O
to	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
increase	O
the	O
number	O
of	O
immature	O
neurons	B:C0027882
in	O
the	O
hippocampal	O
DG	O
of	O
adult	O
rats	O
.	O

We	O
found	O
that	O
administration	O
of	O
isoxazole	O
9	I:C0022266
for	O
14days	O
was	O
able	O
to	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
increase	O
the	O
number	O
of	O
immature	O
neurons	O
in	O
the	O
hippocampal	B:C0019564
DG	O
of	O
adult	O
rats	O
.	O

We	O
found	O
that	O
administration	O
of	O
isoxazole	O
9	I:C0022266
for	O
14days	O
was	O
able	O
to	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
increase	O
the	O
number	O
of	O
immature	O
neurons	O
in	O
the	O
hippocampal	O
DG	B:C0152314
of	O
adult	O
rats	O
.	O

We	O
found	O
that	O
administration	O
of	O
isoxazole	O
9	I:C0022266
for	O
14days	O
was	O
able	O
to	O
potentiate	O
cell	O
proliferation	I:C0596290
and	O
increase	O
the	O
number	O
of	O
immature	O
neurons	O
in	O
the	O
hippocampal	O
DG	O
of	O
adult	O
rats	B:C0086893
.	O

In	O
addition	O
,	O
isoxazole	B:C0022266
9	I:C0022266
treatment	O
was	O
able	O
to	O
completely	O
reverse	O
the	O
marked	O
reduction	O
in	O
these	O
initial	O
stages	O
of	O
the	O
neurogenic	O
process	I:C1518289
observed	O
in	O
vehicle	O
-	O
treated	O
animals	O
(	O
which	O
were	O
submitted	O
to	O
repeated	O
handling	O
and	O
exposure	O
to	O
daily	O
intraperitoneal	O
injections	I:C0021493
)	O
.	O

In	O
addition	O
,	O
isoxazole	O
9	I:C0022266
treatment	B:C0087111
was	O
able	O
to	O
completely	O
reverse	O
the	O
marked	O
reduction	O
in	O
these	O
initial	O
stages	O
of	O
the	O
neurogenic	O
process	I:C1518289
observed	O
in	O
vehicle	O
-	O
treated	O
animals	O
(	O
which	O
were	O
submitted	O
to	O
repeated	O
handling	O
and	O
exposure	O
to	O
daily	O
intraperitoneal	O
injections	I:C0021493
)	O
.	O

In	O
addition	O
,	O
isoxazole	O
9	I:C0022266
treatment	O
was	O
able	O
to	O
completely	O
reverse	O
the	O
marked	O
reduction	O
in	O
these	O
initial	O
stages	O
of	O
the	O
neurogenic	B:C1518289
process	I:C1518289
observed	O
in	O
vehicle	O
-	O
treated	O
animals	O
(	O
which	O
were	O
submitted	O
to	O
repeated	O
handling	O
and	O
exposure	O
to	O
daily	O
intraperitoneal	O
injections	I:C0021493
)	O
.	O

In	O
addition	O
,	O
isoxazole	O
9	I:C0022266
treatment	O
was	O
able	O
to	O
completely	O
reverse	O
the	O
marked	O
reduction	O
in	O
these	O
initial	O
stages	O
of	O
the	O
neurogenic	O
process	I:C1518289
observed	O
in	O
vehicle	B:C0042444
-	O
treated	O
animals	O
(	O
which	O
were	O
submitted	O
to	O
repeated	O
handling	O
and	O
exposure	O
to	O
daily	O
intraperitoneal	O
injections	I:C0021493
)	O
.	O

In	O
addition	O
,	O
isoxazole	O
9	I:C0022266
treatment	O
was	O
able	O
to	O
completely	O
reverse	O
the	O
marked	O
reduction	O
in	O
these	O
initial	O
stages	O
of	O
the	O
neurogenic	O
process	I:C1518289
observed	O
in	O
vehicle	O
-	O
treated	O
animals	B:C0003062
(	O
which	O
were	O
submitted	O
to	O
repeated	O
handling	O
and	O
exposure	O
to	O
daily	O
intraperitoneal	O
injections	I:C0021493
)	O
.	O

In	O
addition	O
,	O
isoxazole	O
9	I:C0022266
treatment	O
was	O
able	O
to	O
completely	O
reverse	O
the	O
marked	O
reduction	O
in	O
these	O
initial	O
stages	O
of	O
the	O
neurogenic	O
process	I:C1518289
observed	O
in	O
vehicle	O
-	O
treated	O
animals	O
(	O
which	O
were	O
submitted	O
to	O
repeated	O
handling	B:C0037793
and	O
exposure	O
to	O
daily	O
intraperitoneal	O
injections	I:C0021493
)	O
.	O

In	O
addition	O
,	O
isoxazole	O
9	I:C0022266
treatment	O
was	O
able	O
to	O
completely	O
reverse	O
the	O
marked	O
reduction	O
in	O
these	O
initial	O
stages	O
of	O
the	O
neurogenic	O
process	I:C1518289
observed	O
in	O
vehicle	O
-	O
treated	O
animals	O
(	O
which	O
were	O
submitted	O
to	O
repeated	O
handling	O
and	O
exposure	O
to	O
daily	O
intraperitoneal	B:C0021493
injections	I:C0021493
)	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	B:C0814002
studies	O
that	O
require	O
repeated	O
handling	O
and	O
manipulation	O
of	O
animals	O
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
differentiation	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	B:C0008972
that	O
require	O
repeated	O
handling	O
and	O
manipulation	O
of	O
animals	O
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
differentiation	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	O
that	O
require	O
repeated	O
handling	B:C0037793
and	O
manipulation	O
of	O
animals	O
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
differentiation	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	O
that	O
require	O
repeated	O
handling	O
and	O
manipulation	B:C0947647
of	O
animals	O
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
differentiation	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	O
that	O
require	O
repeated	O
handling	O
and	O
manipulation	O
of	O
animals	B:C0003062
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
differentiation	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	O
that	O
require	O
repeated	O
handling	O
and	O
manipulation	O
of	O
animals	O
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	B:C0019564
cell	O
proliferation	I:C0596290
and	O
neuronal	O
differentiation	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	O
that	O
require	O
repeated	O
handling	O
and	O
manipulation	O
of	O
animals	O
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	O
cell	B:C0596290
proliferation	I:C0596290
and	O
neuronal	O
differentiation	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	O
that	O
require	O
repeated	O
handling	O
and	O
manipulation	O
of	O
animals	O
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	O
cell	O
proliferation	I:C0596290
and	O
neuronal	B:C0027882
differentiation	O
.	O

Based	O
on	O
these	O
results	O
,	O
we	O
recommend	O
that	O
future	O
neurogenesis	O
studies	O
that	O
require	O
repeated	O
handling	O
and	O
manipulation	O
of	O
animals	O
should	O
include	O
a	O
naïve	O
(	O
non-manipulated	O
)	O
control	O
to	O
determine	O
the	O
baseline	O
levels	O
of	O
hippocampal	O
cell	O
proliferation	I:C0596290
and	O
neuronal	O
differentiation	B:C0007589
.	O

Overall	O
,	O
these	O
findings	B:C2825141
demonstrate	O
that	O
isoxazole	O
9	I:C0022266
is	O
a	O
promising	O
synthetic	O
compound	O
for	O
the	O
mitigation	O
of	O
stress	O
-	O
induced	O
deficits	O
in	O
adult	O
hippocampal	O
neurogenesis	O
.	O

Overall	O
,	O
these	O
findings	O
demonstrate	O
that	O
isoxazole	B:C0022266
9	I:C0022266
is	O
a	O
promising	O
synthetic	O
compound	O
for	O
the	O
mitigation	O
of	O
stress	O
-	O
induced	O
deficits	O
in	O
adult	O
hippocampal	O
neurogenesis	O
.	O

Overall	O
,	O
these	O
findings	O
demonstrate	O
that	O
isoxazole	O
9	I:C0022266
is	O
a	O
promising	O
synthetic	O
compound	B:C1254351
for	O
the	O
mitigation	O
of	O
stress	O
-	O
induced	O
deficits	O
in	O
adult	O
hippocampal	O
neurogenesis	O
.	O

Overall	O
,	O
these	O
findings	O
demonstrate	O
that	O
isoxazole	O
9	I:C0022266
is	O
a	O
promising	O
synthetic	O
compound	O
for	O
the	O
mitigation	O
of	O
stress	B:C0038435
-	O
induced	O
deficits	O
in	O
adult	O
hippocampal	O
neurogenesis	O
.	O

Overall	O
,	O
these	O
findings	O
demonstrate	O
that	O
isoxazole	O
9	I:C0022266
is	O
a	O
promising	O
synthetic	O
compound	O
for	O
the	O
mitigation	O
of	O
stress	O
-	O
induced	O
deficits	O
in	O
adult	O
hippocampal	B:C0019564
neurogenesis	O
.	O

Overall	O
,	O
these	O
findings	O
demonstrate	O
that	O
isoxazole	O
9	I:C0022266
is	O
a	O
promising	O
synthetic	O
compound	O
for	O
the	O
mitigation	O
of	O
stress	O
-	O
induced	O
deficits	O
in	O
adult	O
hippocampal	O
neurogenesis	B:C0814002
.	O

Future	O
studies	B:C0008972
are	O
thus	O
warranted	O
to	O
evaluate	O
the	O
pro-neurogenic	O
properties	O
of	O
isoxazole	O
9	I:C0022266
in	O
animal	O
models	I:C0599779
of	O
affective	O
and	O
neurological	O
disorders	I:C0027765
associated	O
with	O
impaired	O
hippocampal	O
structural	O
plasticity	O
.	O

Future	O
studies	O
are	O
thus	O
warranted	O
to	O
evaluate	B:C0220825
the	O
pro-neurogenic	O
properties	O
of	O
isoxazole	O
9	I:C0022266
in	O
animal	O
models	I:C0599779
of	O
affective	O
and	O
neurological	O
disorders	I:C0027765
associated	O
with	O
impaired	O
hippocampal	O
structural	O
plasticity	O
.	O

Future	O
studies	O
are	O
thus	O
warranted	O
to	O
evaluate	O
the	O
pro-neurogenic	O
properties	O
of	O
isoxazole	B:C0022266
9	I:C0022266
in	O
animal	O
models	I:C0599779
of	O
affective	O
and	O
neurological	O
disorders	I:C0027765
associated	O
with	O
impaired	O
hippocampal	O
structural	O
plasticity	O
.	O

Future	O
studies	O
are	O
thus	O
warranted	O
to	O
evaluate	O
the	O
pro-neurogenic	O
properties	O
of	O
isoxazole	O
9	I:C0022266
in	O
animal	B:C0599779
models	I:C0599779
of	O
affective	O
and	O
neurological	O
disorders	I:C0027765
associated	O
with	O
impaired	O
hippocampal	O
structural	O
plasticity	O
.	O

Future	O
studies	O
are	O
thus	O
warranted	O
to	O
evaluate	O
the	O
pro-neurogenic	O
properties	O
of	O
isoxazole	O
9	I:C0022266
in	O
animal	O
models	I:C0599779
of	O
affective	B:C0525045
and	O
neurological	O
disorders	I:C0027765
associated	O
with	O
impaired	O
hippocampal	O
structural	O
plasticity	O
.	O

Future	O
studies	O
are	O
thus	O
warranted	O
to	O
evaluate	O
the	O
pro-neurogenic	O
properties	O
of	O
isoxazole	O
9	I:C0022266
in	O
animal	O
models	I:C0599779
of	O
affective	O
and	O
neurological	B:C0027765
disorders	I:C0027765
associated	O
with	O
impaired	O
hippocampal	O
structural	O
plasticity	O
.	O

Future	O
studies	O
are	O
thus	O
warranted	O
to	O
evaluate	O
the	O
pro-neurogenic	O
properties	O
of	O
isoxazole	O
9	I:C0022266
in	O
animal	O
models	I:C0599779
of	O
affective	O
and	O
neurological	O
disorders	I:C0027765
associated	O
with	O
impaired	O
hippocampal	B:C0019564
structural	O
plasticity	O
.	O

